Neuschwander-Tetri BA, Loomba R, Sanyal AJ et al (2015) Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
J.MellstromK.MalmJ
At a concentration threshold of approximately 24 g/mL, LAE102 exhibited nonlinear clearance saturation, consistent with its sustained pharmacodynamic (PD) effects, maintaining activin A levels at more than twice the baseline
Factors influencing recovery may include the duration of treatment, dosage, individual patient characteristics, and whether any underlying gastric motility issues existed prior to starting Ozempic
Many people successfully maintain their weight loss on semaglutide after reaching their goal weight on tirzepatide